MiMedx Group, Inc. (MDXG)
3.415
-0.02
(-0.44%)
USD |
NASDAQ |
Apr 17, 16:00
3.42
0.00 (0.00%)
After-Hours: 20:00
MiMedx Group EPS Diluted (Quarterly) : 0.1012 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 1.596 |
| MannKind Corp. | -0.0519 |
| ADMA Biologics, Inc. | 0.2025 |
| Viridian Therapeutics, Inc. | -1.080 |
| Arcus Biosciences, Inc. | -0.8945 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 15.19M |
| Revenue (Quarterly) | 118.10M |
| Total Expenses (Quarterly) | 102.90M |
| Enterprise Value | 363.77M |
| Gross Profit Margin (Quarterly) | 83.76% |
| Profit Margin (Quarterly) | 12.86% |
| Earnings Yield | 9.50% |
| Operating Earnings Yield | 12.50% |
| Normalized Earnings Yield | 9.496 |